Annual Cash & Cash Equivalents
$47.92 M
-$17.14 M-26.35%
December 1, 2024
Summary
- As of March 13, 2025, ADPT annual cash & cash equivalents is $47.92 million, with the most recent change of -$17.14 million (-26.35%) on December 1, 2024.
- During the last 3 years, ADPT annual cash & cash equivalents has fallen by -$91.14 million (-65.54%).
- ADPT annual cash & cash equivalents is now -65.54% below its all-time high of $139.06 million, reached on December 31, 2021.
Performance
ADPT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$47.92 M
+$9.84 M+25.83%
December 1, 2024
Summary
- As of March 13, 2025, ADPT quarterly cash and cash equivalents is $47.92 million, with the most recent change of +$9.84 million (+25.83%) on December 1, 2024.
- Over the past year, ADPT quarterly cash and cash equivalents has increased by +$9.84 million (+25.83%).
- ADPT quarterly cash and cash equivalents is now -90.36% below its all-time high of $497.08 million, reached on September 30, 2020.
Performance
ADPT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ADPT Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -26.4% | +25.8% |
| 3 y3 years | -65.5% | -37.3% |
| 5 y5 years | -50.4% | -37.3% |
ADPT Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -65.5% | at low | -78.0% | +25.8% |
| 5 y | 5-year | -65.5% | at low | -90.4% | +25.8% |
| alltime | all time | -65.5% | at low | -90.4% | +25.8% |
Adaptive Biotechnologies Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $47.92 M(-26.3%) | $47.92 M(+25.8%) |
| Sep 2024 | - | $38.08 M(-36.3%) |
| Jun 2024 | - | $59.82 M(-16.0%) |
| Mar 2024 | - | $71.23 M(+9.5%) |
| Dec 2023 | $65.06 M(-27.7%) | $65.06 M(-26.7%) |
| Sep 2023 | - | $88.71 M(-18.8%) |
| Jun 2023 | - | $109.24 M(+15.5%) |
| Mar 2023 | - | $94.61 M(+5.1%) |
| Dec 2022 | $90.03 M(-35.3%) | $90.03 M(-58.6%) |
| Sep 2022 | - | $217.55 M(+184.7%) |
| Jun 2022 | - | $76.41 M(-33.4%) |
| Mar 2022 | - | $114.81 M(-17.4%) |
| Dec 2021 | $139.06 M | $139.06 M(+13.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $122.40 M(-33.5%) |
| Jun 2021 | - | $184.19 M(+6.1%) |
| Mar 2021 | - | $173.62 M(+40.7%) |
| Dec 2020 | $123.44 M(+27.8%) | $123.44 M(-75.2%) |
| Sep 2020 | - | $497.08 M(+36.0%) |
| Jun 2020 | - | $365.44 M(+71.8%) |
| Mar 2020 | - | $212.69 M(+120.2%) |
| Dec 2019 | $96.58 M(+75.5%) | $96.58 M(+28.9%) |
| Sep 2019 | - | $74.94 M(+54.7%) |
| Jun 2019 | - | $48.46 M(-56.5%) |
| Mar 2019 | - | $111.29 M(+102.2%) |
| Dec 2018 | $55.03 M(-35.5%) | $55.03 M |
| Dec 2017 | $85.31 M | - |
FAQ
- What is Adaptive Biotechnologies annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies annual cash & cash equivalents year-on-year change?
- What is Adaptive Biotechnologies quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies quarterly cash and cash equivalents year-on-year change?
What is Adaptive Biotechnologies annual cash & cash equivalents?
The current annual cash & cash equivalents of ADPT is $47.92 M
What is the all time high annual cash & cash equivalents for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high annual cash & cash equivalents is $139.06 M
What is Adaptive Biotechnologies annual cash & cash equivalents year-on-year change?
Over the past year, ADPT annual cash & cash equivalents has changed by -$17.14 M (-26.35%)
What is Adaptive Biotechnologies quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ADPT is $47.92 M
What is the all time high quarterly cash and cash equivalents for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high quarterly cash and cash equivalents is $497.08 M
What is Adaptive Biotechnologies quarterly cash and cash equivalents year-on-year change?
Over the past year, ADPT quarterly cash and cash equivalents has changed by +$9.84 M (+25.83%)